Take the quiz

One hour of CME credit is available for this module.  If you have already registered, click on take the quiz and enter your username and password.  If you have not already registered, click here.  The $35 fee for this activity covers all four modules and a total of eight credits.  You can read more about this activity, including ACCME-required information, here.

References

1. American Cancer Society web site, Detailed Guide: Colon and Rectal Cancer,http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=10  Accessed 2/16/2007.


2. Levin B, Lieberman DA, McFarland M, et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.  CA Cancer J Clin.  March 5, 2008; e-pub ahead of print.


3. Selected cancers: Colon and rectum. In: Facts & Figures 2003. Atlanta: American Cancer Society, 2003: 11-12.


4. The State of Health Care Quality Screening 2004 New Measure: Colorectal Cancer Screening.  Accessed 2/16/07.


5. Winawer S, Fletcher R, Rex D, et al. American Gastroenterological Association: Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003, 124: 544-560


6. Walsh JM, Terdiman JP. Colorectal Cancer Screening: Scientific Review. Journal of the American Medical Association 2003, 289: 1288-1296.


7. Kim EC, Lance P. Colorectal polyps and their relationship to cancer. Gastroenterology Clinics of North America 1997, 26(1): 1-17.


8. Winawer SJ. Natural History of Colorectal Cancer. Am J Med. 1999;106(1A):3S-6S.


9. Screening for Colorectal Cancer. In: Guide to Clinical Preventive Services, 2006:  Recommendations of the U.S. Preventive Services Task Force. AHRQ, 2006.


10. United States Preventive Services Task Force. Screening for colorectal cancer: Recommendations and rationale. Annals of Internal Medicine 2002; 137:129-131.  Available at: http://www.ahrq.gov/clinic/3rduspstf/colorectal/colorr.htm.


11. Pignone M, Campbell MK, Carr C, et al. Meta-analysis of dietary restriction during fecal occult blood testing. Effective Clinical Practice 2001; 4:150-156.


12. Wineman AP. Screening for colorectal cancer: Guidelines for choosing the appropriate test for each patient. Postgraduate Medicine 2003, 113(2): 49-55.


13. Cancer Facts and Figures 2008.  Atlanta: American Cancer Society, 2008.


14. American Cancer Society Guidelines on Screening and Surveillance for the Early Detection of Adenomatous Polyps and Colorectal Cancer. CA-A Cancer Journal for Clinicians. January/February 2001, Vol. 51/No. 1, 44-54


15. U.S. Preventive Services Task Force. Screening for Colorectal Cancer: Recommendations and Rationale. July 2002. Agency for Healthcare Research and Quality, Rockville, MD.http://www.ahrq.gov/clinic/3rduspstf/colorectal/colorr.htm


16. Smith A, Young GP, Cole SR, Bampton P.  Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.  Cancer. 2006 Nov 1;107(9):2152-9.


17. Levin B, Brooks D, Smith RA, Stone A.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers.  CA A Cancer Journal for Clinicians 2003;53;44-55.


18. Cancer Facts and Figures for African Americans, 2007-2008  Atlanta: American Cancer Society, 2007.


19. Cancer Prevention and Early Detection Facts and Figures, 2007  Atlanta: American Cancer Society, 2007.


20. Cancer Facts and Figures for Hispanics, 2003-2005.  Atlanta: American Cancer Society, 2007.
    
    
21. SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD.  Accessed online March 25, 2008 at http://seer.cancer.gov/csr/1975_2004.